从斑马鱼幼虫中分离肠道进行单细胞RNA测序

Executive Industry Relevance

Single-cell RNA sequencing of zebrafish larval gut enables high-resolution mapping of intestinal cell diversity during development and disease modeling. This protocol supports early-stage target validation and mechanistic de-risking for gastrointestinal research portfolios. The approach enhances predictive confidence in disease-relevant system selection and translational biomarker discovery.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables interrogation of cell-type specific transcriptomes in a vertebrate model.
• Supports functional target validation by isolating enteric neurons, glia, and immune cells.
• Facilitates mechanistic de-risking for neuromuscular and epithelial targets in GI disorders.

Screening & Assay Development

• Provides validated, viable single-cell suspensions for downstream transcriptomic assays.
• Standardizes cell isolation and sorting for reproducible quantitative outputs.
• Enables scalable preparation of gut-derived cells for high-throughput screening platforms.

Translational & Preclinical Research

• Aligns zebrafish gut cell composition with disease-relevant human GI biology.
• Supports continuity from discovery through preclinical validation of GI targets.
• Enables risk-adjusted advancement of candidate targets based on cell-type specific expression profiles.

Pipeline & Workflow Integration

This protocol integrates into the discovery-to-preclinical continuum by enabling isolation and profiling of gut cell types for target identification, validation, and mechanistic studies.

• Discovery Biology: Supports hypothesis testing on GI development and dysfunction at single-cell resolution.
• Screening: Delivers reproducible, viable cell populations for transcriptomic and phenotypic assays.
• Analytics: Provides quantitative gene expression data for comparative analysis across cell types and conditions.
• Translational Research: Bridges zebrafish and human GI biology for biomarker alignment and disease modeling.
• Enterprise Reuse: Establishes a reusable workflow for gut cell isolation and single-cell analysis in diverse GI research programs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in GI target selection and mechanistic understanding.
• Operational Value: Standardizes cell isolation and sorting for reproducibility and scalability.
• Strategic Value: Improves go/no-go decisions by enabling cell-type specific transcriptomic insights.
• Portfolio Impact: Supports risk-adjusted prioritization of GI targets and disease models.

Implementation Considerations

• Requires expertise in zebrafish handling, dissection, and single-cell workflows.
• Needs access to FACS instrumentation and single-cell RNA sequencing platforms.
• Demands cross-team standardization for reproducible cell isolation and sorting.
• Adaptation may be needed for other developmental stages or model organisms.
• Cell viability and yield depend on precise dissection and enzymatic dissociation steps.

Biopharma FAQs